Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates and cancer.

Rowan J Milner1, James Farese, Carolyn J Henry

  • 1Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0126, USA. milnerr@mail.vetmed.ufl.edu

Journal of Veterinary Internal Medicine
|November 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Dual-Pronged Hafnia-Prodrug-Lipid Nanoplatform Coupling Radiosensitization and DNA Homologous Recombination Inhibition.

ACS nano medicine·2026
Same author

A review of spontaneous bone metastases in domestic and laboratory animals.

Journal of bone oncology·2026
Same author

Spatial transcriptomic mapping of canine osteosarcoma reveals immune microenvironment features linked to survival.

Communications biology·2026
Same author

Loss of Mast cells and histaminergic signaling link diet to platelet-mediated NETosis and mammary cancer recurrence.

bioRxiv : the preprint server for biology·2026
Same author

Exosome-niosome hybrid oxygen carrier for protection against acetaminophen-induced acute liver injury.

Biomaterials science·2026
Same author

Osteosarcoma cells promote intracellular iron detoxification to mitigate GPX4-mediated ferroptosis.

Cancer gene therapy·2026

Bisphosphonates, used in oncology, inhibit bone resorption by affecting osteoclasts. Further research is needed to determine their efficacy and safety in canine cancer patients.

Area of Science:

  • Pharmacology
  • Oncology
  • Veterinary Medicine

Background:

  • Bisphosphonates are drugs that inhibit bone resorption.
  • They are classified into non-amino- and amino-bisphosphonates, with the latter being more potent.
  • Their mechanism involves inhibiting osteoclast activity through energy metabolism or mevalonate pathway disruption.

Purpose of the Study:

  • To review the pharmacological properties and mechanisms of action of bisphosphonates.
  • To explore their potential clinical applications in human oncology.
  • To highlight the need for research in veterinary oncology, specifically in dogs with cancer.

Main Methods:

  • Literature review of bisphosphonate pharmacology, mechanisms, and clinical applications.
  • Examination of bisphosphonate effects on cancer cells, angiogenesis, and immune factors.

Related Experiment Videos

  • Assessment of known adverse effects and the current lack of data in canine cancer.

    • Main Results:

    • Bisphosphonates inhibit osteoclast activity and cancer cell proliferation.
    • They have potential roles in managing hypercalcemia, bone metastasis, and pain in cancer patients.
    • Adverse effects include esophagitis, gastritis, and impaired bone repair.

    Conclusions:

    • Bisphosphonates exhibit diverse anti-cancer properties beyond bone resorption inhibition.
    • Clinical applications in human oncology are established, but data in veterinary oncology is scarce.
    • Further investigation is crucial to establish the safety and efficacy of bisphosphonates in dogs with cancer.